EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Danaher's Enterprise Value is $196,763 Mil.
Danaher's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $4,800 Mil. Therefore, Danaher's EV-to-EBIT for today is 40.99.
The historical rank and industry rank for Danaher's EV-to-EBIT or its related term are showing as below:
DHR'
s EV-to-EBIT Range Over the Past 10 Years
Min: 9.23 Med: 25.59 Max: 42.4
Current: 40.99
During the past 13 years, the highest EV-to-EBIT of Danaher was 42.40. The lowest was 9.23. And the median was 25.59.
DHR's EV-to-EBIT is ranked worse than 79.44% of 107
companies
in the Medical Diagnostics & Research industry
Industry Median: 20.2
vs DHR: 40.99
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Danaher's Enterprise Value for the quarter that ended in Mar. 2024 was $196,080 Mil.
Danaher's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $4,800 Mil. Danaher's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.45%.
Danaher EV-to-EBIT Historical Data
The historical data trend for Danaher's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Danaher's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Danaher's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Danaher's EV-to-EBIT falls into.
Danaher's current Enterprise Value is $196,763 Mil.
Danaher's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,800 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danaher (NYSE:DHR) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Danaher's Enterprise Value for the quarter that ended in Mar. 2024 was $196,080 Mil.
Danaher's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,800 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danaher EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Danaher's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHR has been successfully added to your 